N-(2-Pyrazinylcarbonyl)-L-phenylalanine: A Vital Intermediate for Bortezomib Synthesis and Pharmaceutical Innovation

Unlock advancements in cancer treatment with this critical pharmaceutical intermediate.

Get a Quote & Sample

Key Advantages

Exceptional Purity

With a purity level of ≥98%, this intermediate minimizes unwanted side reactions, ensuring a cleaner synthesis pathway for complex APIs.

Critical for Oncology APIs

Its primary function as a Bortezomib intermediate makes it indispensable for companies developing advanced cancer therapies, contributing to breakthroughs in patient care.

Stable and Reliable

Proper storage ensures its stability, making it a dependable component in rigorous pharmaceutical manufacturing processes, a key aspect when sourcing it via CAS 114457-94-2.

Key Applications

Bortezomib Synthesis

This compound is the cornerstone for manufacturing Bortezomib, a proteasome inhibitor critical in treating specific cancers. Reliable supply chains for this N-(2-Pyrazinylcarbonyl)-L-phenylalanine are essential.

Pharmaceutical Intermediate Supply

As a key pharmaceutical intermediate, it supports the broader fine chemical industry, enabling the production of various complex drug molecules and research compounds.

Chemical Research & Development

Its unique chemical structure makes it a subject of interest for further research and development in organic synthesis and medicinal chemistry.

Oncology Drug Manufacturing

Essential for pharmaceutical companies specializing in oncology, ensuring consistent availability of intermediates for life-saving treatments.